Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Newton, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Newton, R.
Thorax 2000;55:603-613 ( July )

Occasional review

Molecular mechanisms of glucocorticoid action: what is important?

Robert Newton

Department of Thoracic Medicine, National Heart & Lung Institute, Imperial College School of Medicine, Dovehouse Street, London SW3 6LY, UK

Correspondence to: Dr R Newton email: robert.newton@ic.ac.uk

Received 28 February 2000; Accepted for publication 1 March 2000

The first 150 words of the full text of this article appear below.

    Biological effects of glucocorticoids

Inflammatory diseases such as asthma and rheumatoid arthritis are characterised at the molecular level by chronically increased expression of multiple cytokines, chemokines, kinins and their receptors, adhesion molecules, and inflammatory enzymes such as inducible nitric oxide synthase (iNOS) and the inducible cyclooxygenase (COX-2).1 At the cellular level, inflamed regions show a substantial influx of various inflammatory cells, arterial dilation, increased blood flow, plasma protein leakage, and oedema whilst, in the case of chronic asthma, substantial remodelling of the airways is observed involving excessive smooth muscle proliferation. However, these parameters of inflammation are effectively reduced by treatment with glucocorticoids by both direct and indirect mechanisms.2 3 For example, the reduced eosinophilia following glucocorticoid treatment in asthmatic subjects arises by direct promotion of eosinophil apoptosis and indirectly by suppressing receptor expression and production of cytokines or growth factors.4 These include factors such as interleukin (IL)-3, IL-5, granulocyte-macrophage colony stimulating factor (GM-CSF), and eotaxin . . . [Full text of this article]




This article has been cited by other articles:


Home page
J. Gen. Virol.Home page
J. D. Easterbrook and S. L. Klein
Corticosteroids modulate Seoul virus infection, regulatory T-cell responses and matrix metalloprotease 9 expression in male, but not female, Norway rats
J. Gen. Virol., November 1, 2008; 89(11): 2723 - 2730.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. R. Clark, J. R. S. Martins, and C. R. Tchen
Role of Dual Specificity Phosphatases in Biological Responses to Glucocorticoids
J. Biol. Chem., September 19, 2008; 283(38): 25765 - 25769.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
T. Quante, Y. C. Ng, E. E. Ramsay, S. Henness, J. C. Allen, J. Parmentier, Q. Ge, and A. J. Ammit
Corticosteroids Reduce IL-6 in ASM Cells via Up-Regulation of MKP-1
Am. J. Respir. Cell Mol. Biol., August 1, 2008; 39(2): 208 - 217.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
B. P. Griffith, M. Haddad, and R. S. Poston
Immunobiology of Heart and Heart-Lung Transplantation
Card. Surg. Adult, January 1, 2008; 3(2008): 1513 - 1538.
[Full Text]


Home page
Biol. Reprod.Home page
C. Guo, Z. Yang, W. Li, P. Zhu, L. Myatt, and K. Sun
Paradox of Glucocorticoid-Induced Cytosolic Phospholipase A2 Group IVA Messenger RNA Expression Involves Glucocorticoid Receptor Binding to the Promoter in Human Amnion Fibroblasts
Biol Reprod, January 1, 2008; 78(1): 193 - 197.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. Newton and N. S. Holden
Separating Transrepression and Transactivation: A Distressing Divorce for the Glucocorticoid Receptor?
Mol. Pharmacol., October 1, 2007; 72(4): 799 - 809.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Ishaq, G. DeGray, K. Mou, A. Aguilera, J. Yang, R. A. Lempicki, A. Hazen, and V. Natarajan
Zap70 Signaling Pathway Mediates Glucocorticoid Receptor-Dependent Transcriptional Activation: Role in the Regulation of Annexin 1 Expression in T Cells
J. Immunol., September 15, 2007; 179(6): 3851 - 3858.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
X. Huang, B. Jiao, C. K. Fung, Y. Zhang, W. K K Ho, C. B. Chan, H. Lin, D. Wang, and C. H K Cheng
The presence of two distinct prolactin receptors in seabream with different tissue distribution patterns, signal transduction pathways and regulation of gene expression by steroid hormones
J. Endocrinol., August 1, 2007; 194(2): 373 - 392.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. K. Lovgren, M. Kovarova, and B. H. Koller
cPGES/p23 Is Required for Glucocorticoid Receptor Function and Embryonic Growth but Not Prostaglandin E2 Synthesis
Mol. Cell. Biol., June 15, 2007; 27(12): 4416 - 4430.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
O. A. Huynh, T. Hampartzoumian, J. P. Arm, J. Hunt, L. Borges, M. Ahern, M. Smith, C. L. Geczy, H. P. McNeil, and N. Tedla
Down-regulation of leucocyte immunoglobulin-like receptor expression in the synovium of rheumatoid arthritis patients after treatment with disease-modifying anti-rheumatic drugs
Rheumatology, May 1, 2007; 46(5): 742 - 751.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Dhawan, B. Liu, B. C. Blaxall, and M. B. Taubman
A Novel Role for the Glucocorticoid Receptor in the Regulation of Monocyte Chemoattractant Protein-1 mRNA Stability
J. Biol. Chem., April 6, 2007; 282(14): 10146 - 10152.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. G. Tasker, S. Di, and R. Malcher-Lopes
Rapid Glucocorticoid Signaling via Membrane-Associated Receptors
Endocrinology, December 1, 2006; 147(12): 5549 - 5556.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. E. Chivers, W. Gong, E. M. King, J. Seybold, J. C. Mak, L. E. Donnelly, N. S. Holden, and R. Newton
Analysis of the Dissociated Steroid RU24858 Does Not Exclude a Role for Inducible Genes in the Anti-Inflammatory Actions of Glucocorticoids
Mol. Pharmacol., December 1, 2006; 70(6): 2084 - 2095.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
S. M. Abraham, T. Lawrence, A. Kleiman, P. Warden, M. Medghalchi, J. Tuckermann, J. Saklatvala, and A. R. Clark
Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1
J. Exp. Med., August 7, 2006; 203(8): 1883 - 1889.
[Abstract] [Full Text] [PDF]


Home page
J Intensive Care MedHome page
M. Cepkova and M. A. Matthay
Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome.
J Intensive Care Med, May 1, 2006; 21(3): 119 - 143.
[Abstract] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Inayama, Y. Nishioka, M. Azuma, S. Muto, Y. Aono, H. Makino, K. Tani, H. Uehara, K. Izumi, A. Itai, et al.
A Novel I{kappa}B Kinase-beta Inhibitor Ameliorates Bleomycin-induced Pulmonary Fibrosis in Mice
Am. J. Respir. Crit. Care Med., May 1, 2006; 173(9): 1016 - 1022.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
B. T. Vander Kooi, H. Onuma, J. K. Oeser, C. A. Svitek, S. R. Allen, C. W. Vander Kooi, W. J. Chazin, and R. M. O'Brien
The Glucose-6-Phosphatase Catalytic Subunit Gene Promoter Contains Both Positive and Negative Glucocorticoid Response Elements
Mol. Endocrinol., December 1, 2005; 19(12): 3001 - 3022.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. R. Almon, W. Lai, D. C. DuBois, and W. J. Jusko
Corticosteroid-regulated genes in rat kidney: mining time series array data
Am J Physiol Endocrinol Metab, November 1, 2005; 289(5): E870 - E882.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
V. C. Jordan
Medroxyprogesterone Acetate and Metastases: Of Mice and (wo)Men
J Natl Cancer Inst, May 4, 2005; 97(9): 619 - 621.
[Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Ialenti, G. Grassia, P. Di Meglio, P. Maffia, M. Di Rosa, and A. Ianaro
Mechanism of the Anti-Inflammatory Effect of Thiazolidinediones: Relationship with the Glucocorticoid Pathway
Mol. Pharmacol., May 1, 2005; 67(5): 1620 - 1628.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
L.-G. Bladh, J. Liden, A. Pazirandeh, I. Rafter, K. Dahlman-Wright, S. Nilsson, and S. Okret
Identification of Target Genes Involved in the Antiproliferative Effect of Glucocorticoids Reveals a Role for Nuclear Factor-{kappa}B Repression
Mol. Endocrinol., March 1, 2005; 19(3): 632 - 643.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. O. Leonard, C. Godson, H. R. Brady, and C. T. Taylor
Potentiation of Glucocorticoid Activity in Hypoxia through Induction of the Glucocorticoid Receptor
J. Immunol., February 15, 2005; 174(4): 2250 - 2257.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
A Cote-Velez, L Perez-Martinez, M Y Diaz-Gallardo, C Perez-Monter, A Carreon-Rodriguez, J-L Charli, and P Joseph-Bravo
Dexamethasone represses cAMP rapid upregulation of TRH gene transcription: identification of a composite glucocorticoid response element and a cAMP response element in TRH promoter
J. Mol. Endocrinol., February 1, 2005; 34(1): 177 - 197.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
W. Lu, E. P. Lillehoj, and K. C. Kim
Effects of dexamethasone on Muc5ac mucin production by primary airway goblet cells
Am J Physiol Lung Cell Mol Physiol, January 1, 2005; 288(1): L52 - L60.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
C. Stellato
Post-transcriptional and Nongenomic Effects of Glucocorticoids
Proceedings of the ATS, November 1, 2004; 1(3): 255 - 263.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
L. E. Donnelly, R. Newton, G. E. Kennedy, P. S. Fenwick, R. H. F. Leung, K. Ito, R. E. K. Russell, and P. J. Barnes
Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms
Am J Physiol Lung Cell Mol Physiol, October 1, 2004; 287(4): L774 - L783.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
M. W. Bergmann, K. J. Staples, S. J. Smith, P. J. Barnes, and R. Newton
Glucocorticoid Inhibition of Granulocyte Macrophage-Colony-Stimulating Factor from T cells Is Independent of Control by Nuclear Factor-{kappa}B and Conserved Lymphokine Element 0
Am. J. Respir. Cell Mol. Biol., April 1, 2004; 30(4): 555 - 563.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Castro, S. R. Bloch, M. V. Jenkerson, S. DeMartino, D. L. Hamilos, R. B. Cochran, X. E. L. Zhang, H. Wang, J. P. Bradley, K. B. Schechtman, et al.
Asthma Exacerbations after Glucocorticoid Withdrawal Reflects T Cell Recruitment to the Airway
Am. J. Respir. Crit. Care Med., April 1, 2004; 169(7): 842 - 849.
[Abstract] [Full Text] [PDF]


Home page
J Intensive Care MedHome page
R. S. Poston and B. P. Griffith
Heart Transplantation
J Intensive Care Med, January 1, 2004; 19(1): 3 - 12.
[Abstract] [PDF]


Home page
Mol. Endocrinol.Home page
J. Wu, Y. Li, J. Dietz, and D. S. Lala
Repression of p65 Transcriptional Activation by the Glucocorticoid Receptor in the Absence of Receptor-Coactivator Interactions
Mol. Endocrinol., January 1, 2004; 18(1): 53 - 62.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
P. R. Mittelstadt and J. D. Ashwell
Disruption of Glucocorticoid Receptor Exon 2 Yields a Ligand-Responsive C-Terminal Fragment that Regulates Gene Expression
Mol. Endocrinol., August 1, 2003; 17(8): 1534 - 1542.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H. Tazawa, W. Osman, Y. Shoji, E. Treuter, J.-A. Gustafsson, and J. Zilliacus
Regulation of Subnuclear Localization Is Associated with a Mechanism for Nuclear Receptor Corepression by RIP140
Mol. Cell. Biol., June 15, 2003; 23(12): 4187 - 4198.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
S. K. Roy, J. Wang, and P. Yang
Dexamethasone Inhibits Transforming Growth Factor-{beta} Receptor (T{beta}R) Messenger RNA Expression in Hamster Preantral Follicles: Possible Association with NF-YA
Biol Reprod, June 1, 2003; 68(6): 2180 - 2188.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
R. Silverstein and D. C. Johnson
Endogenous versus exogenous glucocorticoid responses to experimental bacterial sepsis
J. Leukoc. Biol., April 1, 2003; 73(4): 417 - 427.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. V. Culpitt, D. F. Rogers, P. Shah, C. De Matos, R. E. K. Russell, L. E. Donnelly, and P. J. Barnes
Impaired Inhibition by Dexamethasone of Cytokine Release by Alveolar Macrophages from Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., January 1, 2003; 167(1): 24 - 31.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
B. P. Griffith and R. S. Poston
Immunobiology of Heart and Heart-Lung Transplantation
Card. Surg. Adult, January 1, 2003; 2(2003): 1403 - 1426.
[Full Text]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. Barazzone-Argiroffo, A. Pagano, C. Juge, I. Metrailler, A. Rochat, C. Vesin, and Y. Donati
Glucocorticoids aggravate hyperoxia-induced lung injury through decreased nuclear factor-kappa B activity
Am J Physiol Lung Cell Mol Physiol, January 1, 2003; 284(1): L197 - L204.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Lasa, S. M. Abraham, C. Boucheron, J. Saklatvala, and A. R. Clark
Dexamethasone Causes Sustained Expression of Mitogen-Activated Protein Kinase (MAPK) Phosphatase 1 and Phosphatase-Mediated Inhibition of MAPK p38
Mol. Cell. Biol., November 15, 2002; 22(22): 7802 - 7811.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Le Drean, N. Mincheneau, P. Le Goff, and D. Michel
Potentiation of Glucocorticoid Receptor Transcriptional Activity by Sumoylation
Endocrinology, September 1, 2002; 143(9): 3482 - 3489.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. Korhonen, A. Lahti, M. Hamalainen, H. Kankaanranta, and E. Moilanen
Dexamethasone Inhibits Inducible Nitric-Oxide Synthase Expression and Nitric Oxide Production by Destabilizing mRNA in Lipopolysaccharide-Treated Macrophages
Mol. Pharmacol., September 1, 2002; 62(3): 698 - 704.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
W. I. de Boer
Cytokines and Therapy in COPD* : A Promising Combination?
Chest, May 1, 2002; 121(5_suppl): 209S - 218S.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
R. Di Bitondo, A. J. Hall, I. R. Peake, L. Iacoviello, and P. R. Winship
Oestrogenic repression of human coagulation factor VII expression mediated through an oestrogen response element sequence motif in the promoter region
Hum. Mol. Genet., April 1, 2002; 11(7): 723 - 731.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
T W Harrison, A Wisniewski, J Honour, and A E Tattersfield
Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects
Thorax, March 1, 2001; 56(3): 186 - 191.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
M. Lasa, M. Brook, J. Saklatvala, and A. R. Clark
Dexamethasone Destabilizes Cyclooxygenase 2 mRNA by Inhibiting Mitogen-Activated Protein Kinase p38
Mol. Cell. Biol., February 1, 2001; 21(3): 771 - 780.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2000 BMJ Publishing Group Ltd & British Thoracic Society